{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:21:21Z","timestamp":1788348081753,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004686","name":"Deanship of Scientific Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004686","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.xphs.2020.03.009","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T06:56:28Z","timestamp":1584428188000},"page":"2145-2155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Physically Optimized Nano-Lipid Carriers Augment Raloxifene and Vitamin D Oral Bioavailability in Healthy Humans for Management of Osteoporosis"],"prefix":"10.1016","volume":"109","author":[{"given":"Khaled M.","family":"Hosny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahaf H.","family":"Bahmdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil A.","family":"Alhakamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Alfaleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama A.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed H.","family":"Elkomy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.xphs.2020.03.009_bib1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.maturitas.2015.06.009","article-title":"Primary osteoporosis in postmenopausal women","volume":"82","author":"Ji","year":"2015","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.xphs.2020.03.009_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00198-012-2074-y","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"24","author":"Kanis","year":"2013","journal-title":"Osteoporos Int"},{"issue":"Suppl.\u00a04","key":"10.1016\/j.xphs.2020.03.009_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP161435.GL","article-title":"American association of clinical endocrinologists and American college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis - 2016","volume":"22","author":"Camacho","year":"2016","journal-title":"Endocr Pract"},{"issue":"1","key":"10.1016\/j.xphs.2020.03.009_bib4","doi-asserted-by":"crossref","DOI":"10.1007\/s11657-017-0324-5","article-title":"UK clinical guideline for the prevention and treatment of osteoporosis","volume":"12","author":"Compston","year":"2017","journal-title":"Arch Osteoporos"},{"key":"10.1016\/j.xphs.2020.03.009_bib5","first-page":"3","article-title":"Clinical guidelines for the prevention and treatment of osteoporosis: summary statements and recommendations from the Italian Society for Orthopaedics and Traumatology","volume":"18","author":"Tarantino","year":"2017","journal-title":"J\u00a0Orthop Traumatol"},{"issue":"1","key":"10.1016\/j.xphs.2020.03.009_bib6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0301-2115(98)00280-2","article-title":"Clinical efficacy of raloxifene in postmenopausal women","volume":"85","author":"Agnusdei","year":"1999","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"31","key":"10.1016\/j.xphs.2020.03.009_bib7","first-page":"4182","article-title":"Raloxifen","volume":"162","author":"Eriksen","year":"2000","journal-title":"Ugeskr Laeger"},{"issue":"2","key":"10.1016\/j.xphs.2020.03.009_bib8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejps.2013.03.001","article-title":"Effect of UDP-glucuronosyltransferase 1A8 polymorphism on raloxifene glucuronidation","volume":"49","author":"Kokawa","year":"2013","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2020.03.009_bib9","article-title":"Nogg 2017\u00a0: Clinical guideline for prevention and tretment of osteoprosis","author":"Group","year":"2017","journal-title":"NOGG"},{"issue":"6","key":"10.1016\/j.xphs.2020.03.009_bib10","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3109\/10717544.2014.898110","article-title":"Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration","volume":"22","author":"Gaba","year":"2015","journal-title":"Drug Deliv"},{"key":"10.1016\/j.xphs.2020.03.009_bib11","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jddst.2017.06.013","article-title":"Nanostructured lipid carriers as oral delivery systems for poorly soluble drugs","volume":"42","author":"Beloqui","year":"2017","journal-title":"J\u00a0Drug Deliv Sci Technol"},{"key":"10.1016\/j.xphs.2020.03.009_bib12","article-title":"plot3d: tools for plotting 3-D and 2-D data in openGL","author":"Soetaert","year":"2013","journal-title":"R\u00a0Neth Inst Sea Res (Nioz)"},{"issue":"1","key":"10.1016\/j.xphs.2020.03.009_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s13346-017-0449-5","article-title":"Betahistine dihydrochloride transdermal delivery via optimized thermosensitive gels: percutaneous absorption evaluation using rat growth as a biomarker","volume":"8","author":"Elkomy","year":"2018","journal-title":"Drug Deliv Transl Res"},{"issue":"4","key":"10.1016\/j.xphs.2020.03.009_bib14","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/03639045.2016.1268153","article-title":"Development of a nanogel formulation for transdermal delivery of tenoxicam: a pharmacokinetic\u2013pharmacodynamic modeling approach for quantitative prediction of skin absorption","volume":"43","author":"Elkomy","year":"2017","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2020.03.009_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0301-2115(98)00278-4","article-title":"Pharmacokinetics of raloxifene and its clinical application","volume":"85","author":"Hochner-Celnikier","year":"1999","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"12","key":"10.1016\/j.xphs.2020.03.009_bib16","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1021\/tx800323w","article-title":"Effect of intestinal glucuronidation in limiting hepatic exposure and bioactivation of raloxifene in humans and rats","volume":"21","author":"Dalvie","year":"2008","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.xphs.2020.03.009_bib17","doi-asserted-by":"crossref","first-page":"1997S","DOI":"10.3945\/ajcn.2009.27230D","article-title":"Existing and potentially novel functional markers of vitamin D status: a systematic review","volume":"89","author":"Seamans","year":"2009","journal-title":"Am J Clin Nutr"},{"issue":"15","key":"10.1016\/j.xphs.2020.03.009_bib18","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.clinbiochem.2009.07.013","article-title":"An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D","volume":"42","author":"Wagner","year":"2009","journal-title":"Clin Biochem"},{"issue":"1","key":"10.1016\/j.xphs.2020.03.009_bib19","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/10717544.2017.1321061","article-title":"Loratadine bioavailability via buccal transferosomal gel: formulation, statistical optimization, in\u00a0vitro\/in\u00a0vivo characterization, and pharmacokinetics in human volunteers","volume":"24","author":"Elkomy","year":"2017","journal-title":"Drug Deliv"},{"key":"10.1016\/j.xphs.2020.03.009_bib20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.molliq.2018.01.141","article-title":"Silymarin loaded nanostructured lipid carrier: from design and dermatokinetic study to mechanistic analysis of epidermal drug deposition enhancement","volume":"255","author":"Iqbal","year":"2018","journal-title":"J\u00a0Mol Liq"},{"issue":"1","key":"10.1016\/j.xphs.2020.03.009_bib21","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1208\/s12249-009-9190-9","article-title":"Formulation development and bioavailability evaluation of a self-nanoemulsified drug delivery system of oleanolic acid","volume":"10","author":"Xi","year":"2009","journal-title":"AAPS PharmSciTech"},{"issue":"32","key":"10.1016\/j.xphs.2020.03.009_bib22","doi-asserted-by":"crossref","first-page":"19815","DOI":"10.1039\/C6RA27096D","article-title":"Development and characterization of promising Cremophor EL-stabilized o\/w nanoemulsions containing short-chain alcohols as a cosurfactant","volume":"7","author":"Zeng","year":"2017","journal-title":"RSC Adv"},{"issue":"1","key":"10.1016\/j.xphs.2020.03.009_bib23","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ijpharm.2013.03.034","article-title":"Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization","volume":"454","author":"Shete","year":"2013","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2020.03.009_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bfopcu.2016.12.001","article-title":"Formulation design and optimization of novel fast dissolving tablet of chlorpheniramine maleate by using lyophilization techniques","volume":"55","author":"Dave","year":"2017","journal-title":"Bull Fac Pharmacy, Cairo Univ"},{"issue":"1","key":"10.1016\/j.xphs.2020.03.009_bib25","doi-asserted-by":"crossref","DOI":"10.1208\/pt060110","article-title":"Formulation and evaluation of mucoadhesive glipizide microspheres","volume":"6","author":"Patel","year":"2005","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.xphs.2020.03.009_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.carbpol.2006.02.008","article-title":"Characterization of insulin-loaded alginate nanoparticles produced by ionotropic pre-gelation through DSC and FTIR studies","volume":"66","author":"Sarmento","year":"2006","journal-title":"Carbohydr Polym"},{"issue":"2","key":"10.1016\/j.xphs.2020.03.009_bib27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.15171\/apb.2016.021","article-title":"The impact of variables on particle size of solid lipid nanoparticles and nanostructured lipid carriers; A comparative literature review","volume":"6","author":"Bahari","year":"2016","journal-title":"Adv Pharm Bull"},{"issue":"1","key":"10.1016\/j.xphs.2020.03.009_bib28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jcis.2009.03.012","article-title":"Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN)","volume":"334","author":"Helgason","year":"2009","journal-title":"J\u00a0Colloid Interface Sci"},{"issue":"2","key":"10.1016\/j.xphs.2020.03.009_bib29","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1208\/s12249-010-9414-z","article-title":"Development and statistical optimization of solid lipid nanoparticles of simvastatin by using 23 full-factorial design","volume":"11","author":"Shah","year":"2010","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.xphs.2020.03.009_bib30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/masy.200950906","article-title":"Surfactant concentration effects on the aqueous phase polymerization of vinyl acetate","volume":"283-284","author":"Mart\u00ednez-Guti\u00e9rrez","year":"2009","journal-title":"Macromol Symp"},{"issue":"1","key":"10.1016\/j.xphs.2020.03.009_bib31","first-page":"23","article-title":"Formulation and in\u00a0vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers","volume":"19","author":"Thatipamula","year":"2011","journal-title":"Daru, J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2020.03.009_bib32","first-page":"586","article-title":"Transdermal delivery OF azathioprine BY solid lipid nanoparticles: IN-vitro and ex-vivo studies","volume":"10","author":"Syed","year":"2019","journal-title":"Int J Pharm Sci Res"},{"issue":"1","key":"10.1016\/j.xphs.2020.03.009_bib33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejpb.2010.05.003","article-title":"Non-destructive methods of characterization of risperidone solid lipid nanoparticles","volume":"76","author":"Rahman","year":"2010","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2020.03.009_bib34","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.colsurfb.2013.05.041","article-title":"Miconazole-loaded nanostructured lipid carriers (NLC) for local delivery to the oral mucosa: improving antifungal activity","volume":"111","author":"Mendes","year":"2013","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.xphs.2020.03.009_bib35","first-page":"4797","article-title":"Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge","volume":"10","author":"Arzani","year":"2015","journal-title":"Int J Nanomedicine"},{"issue":"8","key":"10.1016\/j.xphs.2020.03.009_bib36","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1517\/17425247.2013.812069","article-title":"The formulation of a nasal nanoemulsion zaleplon in situ gel for the treatment of insomnia","volume":"10","author":"Hosny","year":"2013","journal-title":"Expert Opin Drug Deliv"},{"issue":"2","key":"10.1016\/j.xphs.2020.03.009_bib37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0378-5173(98)00314-7","article-title":"Uptake of PMMA nanoparticles from the gastrointestinal tract after oral administration to rats: modification of the body distribution after suspension in surfactant solutions and in oil vehicles","volume":"176","author":"Araujo","year":"1999","journal-title":"Int J Pharm"},{"issue":"17","key":"10.1016\/j.xphs.2020.03.009_bib38","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.1021\/jf060405o","article-title":"Optimization in the preparation of coenzyme Q10 nanoliposomes","volume":"54","author":"Xia","year":"2006","journal-title":"J\u00a0Agric Food Chem"},{"issue":"1-2","key":"10.1016\/j.xphs.2020.03.009_bib39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijpharm.2009.04.022","article-title":"Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt","volume":"376","author":"Chen","year":"2009","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2020.03.009_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bdd.270","article-title":"Development and validation of a non-linear IVIVC model for a diltiazem extended release Formulation","volume":"23","author":"Sirisuth","year":"2002","journal-title":"Biopharm Drug Dispos"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354920301350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354920301350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:29:45Z","timestamp":1758360585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354920301350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0022354920301350"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2020.03.009","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Physically Optimized Nano-Lipid Carriers Augment Raloxifene and Vitamin D Oral Bioavailability in Healthy Humans for Management of Osteoporosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2020.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}